Thyroid hormone activation in vascular smooth muscle cells is negatively regulated by glucocorticoid

Thyroid

Volumn 19, Issue 7, 2009, Pages 755-763

  Toyoda, Nagaoki ^a   Yasuzawa Amano, Saori ^a   Nomura, Emiko ^a   Yamauchi, Azusa ^a   Nishimura, Kumiko ^a   Ukita, Chizuko ^a   Morimoto, Satoshi ^a   Kosaki, Atsushi ^a   Iwasaka, Toshiji ^a   Harney, John W ^b   Larsen, P Reed ^b   Nishikawa, Mitsushige ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; DEXAMETHASONE; GLUCOCORTICOID; IODOTHYRONINE; LIOTHYRONINE; MESSENGER RNA; METYRAPONE; THYROID HORMONE; THYROXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HORMONE ACTION; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROXINE BLOOD LEVEL; VASCULAR SMOOTH MUSCLE;

EID: 67749124567     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0044     Document Type: Article

References (44)

1. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509.
2. Graettinger JS, Muenster JJ, Cheechia CS 1958 A correlation of clinical and hemodynamic studies in patients with hypothyroidism. J Clin Invest 38:502-510.
3. Ojamaa K, Klemperer JD, Klein I 1996 Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6:505-512.
4. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89.
5. Kuiper GGJM, Kester MHA, Peeters RP, Visser TJ 2005 Biochemical mechanisms of thyroid hormone deiodination. Thyroid 15:787-798.
6. Kohrle J, Jakob F, Contempre B, Dumont LE 2005 Selenium, the thyroid, and the endocrine system. Endocr Rev 26:944-984.
7. Croteau W, Davey JC, Galton VA, St Germain DL 1996 Cloning of the mammalian type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98:405-417.
8. Salvatore D, Tu H, Harney JW, Larsen PR 1996 Type 2 io-dothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98:962-968.
9. Bianco AC, Kim BW 2006 Deiodinase: implications of the local control of thyroid hormone action. J Clin Invest 116:2571-2579.
10. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-2533.
11. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St. Germain DL, Galton VA 2001 Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15:2137-2148.
12. de Jesus LA, Cavalho SD, Ribeiro MO, Schneider M, Kim S-W, Harney JW, Larsen PR, Bianco AC 2001 The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 108:1379-1385.
13. Ng L, Goodyear RJ, Woods CA, Schneider MJ, Diamond E, Richardson GP, Kelley MW, St. Germain DL, Galton VA, Forrest D 2004 Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc Natl Acad Sci USA 101:3474-3479.
14. Mizuma H, Murakami M, Mori M 2001 Thyroid hormone activation in human vascular smooth muscle cells. Circ Res 88:313-318.
15. Maeda A, Toyoda N, Yasuzawa-Amano S, Iwasaka T, Nishikawa M 2003 Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells. Mol Cell Endocrinol 200:111-117.
16. Yasuzawa-Amano S, Toyoda N, Maeda A, Kosaki A, Mori Y, Iwasaka T, Nishikawa M 2004 Expression and regulation of type 2 iodothyronine deiodinase in rat aorta media. Endocrinology 145:5638-5645.
17. Tanaka K, Murakami M, Greer MA 1987 Rhythmicity of tri-iodothyronine generation by type II thyroxine 5′-deiodinase in rat pineal is mediated by a β-adrenergic mechanism. Endocrinology 121:74-77.
18. Osuna C, Jimenez J, Reiter RJ, Rubio A, Guerrero JM 1992 Adrenergic regulation of type II-deiodinase circadian rhythm in rat harderian gland. Am J Physiol 263:E884-E889.
19. Campos-Barros A, Musa A, Flechner A, Hessenius C, Gaio U, Meinhold H, Baumgartner A 1997 Evidence for circadian variations of thyroid hormone concentrations and type II 5′-iodothyronine deiodinase activity in the rat central nervous system. J Neurochem 68:795-803.
20. Kamiya Y, Murakami M, Araki O, Hosoi Y, Ogiwara T, Mizuma H, Mori M 1999 Pretranslational regulation of rhythmic type II iodothyronine deiodinase expression by β-adrenergic mechanism in the rat pineal gland. Endocrinology 140:1272-1278.
21. Araki O, Murakami M, Kamiya Y, Hosoi Y, Ogiwara T, Mizuma H, Iriuchijima T, Mori M 1998 Northern analysis of type II iodothyronine deiodinase mRNA in rat Harderian gland. Life Sci 63:1843-1848.
22. House SD, Ruch S, Koscienski III WF, Rocholl CW, Moldow RL 1997 Effects of the circadian rhythm of corticosteroids on leukocyte-endothelium interactions in the AM and PM. Life Sci 60:2023-2034.
23. St. Germain DL 1986 Hormonal control of a low Km (type II) iodothyronine 5′-deiodinase in cultured NB41A3 mouse neuroblastoma cells. Endocrinology 119:840-846.
24. Hidal JT, Kaplan MM 1988 Inhibition of thyroxine 5′-deiodination type II in cultured human placental cells by cortisol, insulin, 3′,5′-cyclic adenosine monophosphate, and butyrate. Metabolism 37:664-668.
25. Shigeaki S, Oka T 2003 Regulation of type II deiodinase expression by EGF and glucocorticoid in HC11 mouse mammary epithelium. Am J Physiol Endocrinol Metab 284:E1119-E1124.
26. Bogoz Z, Budziszewska B, Kubera M, Basta-Kaim A, Jaworska-Feil L, Skuza G, Lason W 2005 Effect of combined treatment with imipramine and metyrapone on the immobility time, the activity of hypothalamo-pituitary-adrenocortical axis and immunological parameters in the forced swimming test in the rat. J Physiol Pharmacol 56:49-61.
27. Cavalieri RR, Castle JN, McMahon FA 1984 Effects of dexamethasone on kinetics and distribution of triiodothyronine in the rat. Endocrinology 114:215-221.
28. Jennings A, Ferguson DC 1984 Effect of dexamethasone on triiodothyronine production in the perfused rat liver and kidney. Endocrinology 114:31-36.
29. van der Geyten S, Darras VM 2005 Developmentally defined regulation of thyroid hormone metabolism by glucocorticoids in the rat. J Endocrinol 185:327-336.
30. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
31. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
32. Hosoi Y, Murakami M, Mizuma H, Ogiwara T, Imamura M, Mori M 1999 Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J Clin Endocrinol Metab 84:3293-3300.
33. Imai Y, Toyoda N, Maeda A, Kadobayashi T, Wang F, Kuma K, Nishikawa M, Iwasaka T 2001 Type 2 iodothyronine deiodinase expression is upregulated by the PKA-dependent pathway and is downregulated by the PKC-dependent pathway in cultured human thyroid cells. Thyroid 11:899-907.
34. Pallud S, Lennon AM, Ramauge M, Gavaret JM, Croteau W, Pierre M, Courtin F, St. Germain DL 1997 Expression of the type II iodothyronine deiodinase in cultured rat astrocytes is selenium dependent. J Biol Chem 272:18104- 18110.
35. Bartha T, Kim S-W, Salvatore D, Gereben B, Tu HM, Harney JW, Radas P, Larsen PR 2000 Characterization of the 5′-flanking and 5′-untranslated region of the cyclic adenosine 3′, 5′-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology 140:229-237.
36. Canettieri G, Celi FS, Baccheschi G, Sarvatori L, Andreoli M, Centanni M 2000 Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element. Endocrinology 141: 1804-1813.
37. Gereben B, Salvatore D, Harney JW, Tu HM, Larsen PR 2001 The human, but not rat dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1). Mol Endocrinol 15:112-124.
38. Song S, Adachi K, Katsuyama M, Sorimachi K, Oka T 2000 Isolation and characterization of the 5′ -upstream and untranslated regions of the mouse type II iodothyronine deiodinase gene. Mol Cell Endocrinol 165:189-198.
39. Kim SW, Harney JW, Larsen PR 1998 Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology 139:4895-4905.
40. Araki O, Morimura T, Ogiwara T, Mizuma H, Mori M, Murakami M 2003 Expression of type 2 iodothyronine deiodinase in corticotropin-secreting mouse pituitary tumor cells is stimulated by glucocorticoid and corticotropinreleasing hormone. Endocrinology 144:4459-4465.
41. Beato M, Chalepakis G, Schauer M, Slater E 1989 DNA regulatory elements for steroid hormones. J Steroid Biochem 32:737-748.
42. Akerblom IE, Slater EP, Beato M, Baxter JD, Mellon PL 1988 Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 241:350-353.
43. Yang S, Zhang L 2004 Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2:1-12.
44. Whitworth JA, Schyvens CG, Zhang Y, Mangos GJ, Kelly JJ 2001 Glucocorticoid-induced hypertension: from mouse to man. Clin Exp Pharmacol Physiol 28:993-996.